Displaying 1 - 10 of 11 for Lung
  • CareSTEPS Study (H-38998)
    • The purpose of this study to evaluate a program developed for the family caregivers of advanced lung cancer patients.
  • Chronic Refractory Cough Cohort (COCO) (H-41614)
    • The purpose of this study is to test some questionnaires that have been designed to measure cough and its impact on quality of life. It is also being done to establish if people with chronic cough have low levels of zinc in their blood.
  • Chronic Refractory Cough Cohort (COCO) (H-41623)
    • The purpose of this study is to evaluate different doses of the investigational study drug nemiralisib inhalation powder inhaled through the ELLIPTA™ inhaler to see if it is safe and how well it works in improving lung function and in treating COPD.
  • COPD Gene Study (H-22209)
    • If you participated in the COPD Gene Study at Baylor College of Medicine Baylor Clinic between 2008 and 2011, we would like to invite you again for the third phase of this important nationwide study.
  • COPD Study (H-31742)
    • The purpose of this study is to evaluate the safety of long-term use of formoterol fumarate.
  • COPD Study (H-39315)
    • The purpose of this study is to assess the efficacy and safety of PT009 compared to PT005 on COPD exacerbations in subjects with moderate to very severe COPD.
  • COPD Study (H-42163)
    • The purpose of this study is to assess the dose response, efficacy, safety and pharmacokinetics of nemiralisib across a range of doses compared with placebo for treatment of COPD.
  • Cystic Fibrosis Study (H-39723)
    • This study focuses on antibiotic use in cystic fibrosis patients 18 years and older requiring IV antibiotics for treatment of pulmonary exacerbations.
  • Intervention Study in Overweight COPD Patients (H-40335)
    • The purpose of this study is to investigate if a lifestyle program that promotes modest weight loss and increased physical activity will improve COPD symptoms for those with a high BMI.
  • Losartan Effects on Emphysema Progression (LEEP) (H-40418)
    • This study is testing the benefits of an investigational drug in people with COPD.